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Background: Peripheral nerve injury results in chronic neuropathic pain characterized by allodynia and/
or spontaneous pain. It has been suggested that activation of mitogen-activated protein kinases such asKey words:
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extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) contribute to the
neuropathic pain.
Objectives: We investigated if curcumin could prevent the development of neuropathic pain in rats with
chronic constriction injury (CCI) of the sciatic nerve.
Methods: The animals were divided into 3 groups. In the curcumin treatment group (n ¼ 10), curcumin
(50 mg/kg/d PO) was administered once daily from 1 day before CCI to 7 days after CCI. The rats in the
sham group (n ¼ 10) and CCI group (n ¼ 10) received a control vehicle. The mechanical allodynia was
assessed using von Frey at 1, 3, 5, and 7 days after nerve injury. Western blots were used to evaluate the
levels of p-ERK, p-JNK, and phosphorylation of NR1 (p-NR1) subunits of N-methyl-D-aspartate in the
spinal dorsal root ganglion.
Results: In the CCI group, mechanical allodynia was observed during 7 days after nerve injury. However,
curcumin treatment reversed the mechanical allodynia 7 days after nerve ligation. There were no
differences in the expression of p-ERK, p-JNK, and p-NR1 between the sham and curcumin groups.
However, the expression of p-ERK, p-JNK, and p-NR1 in the CCI group were higher than the sham group
and curcumin group, respectively (P o 0.05).
Conclusions: Treatment with curcumin during the early stages of peripheral neuropathy can prevent the
development of chronic neuropathic pain.
& 2013. The Authors. Published by Elsevier Inc. Open access under CC BY license.Introduction
Peripheral nerve injury often results in chronic neuropathic
pain that is characterized by allodynia and/or spontaneous pain.
Treatment of neuropathic pain is a challenge because the under-
lying mechanisms are not clearly understood and current analge-
sics, such as anticonvulsant or opiates, are limited in relieving this
pain because of their partial efﬁcacy and potential toxicity.1ier Inc.
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Open access under CC BY liceRecently, increasing evidence shows that mitogen-activated
protein kinases such as extracellular signal-regulated kinase
(ERK) and c-Jun N-terminal kinase (JNK) play important roles in
the generation of chronic pain such as neuropathic and inﬂam-
matory pain.2–4 The expression of phosphorylated ERK (p-ERK) in
the spinal dorsal ganglion (DRG) has been implicated in the
induction of neuropathic pain behavior in rat models of chronic
constriction injury (CCI) and its normalization after decompres-
sion of CCI reﬂects the reversal of the pain behaviors.5 The
expression of phosphorylated JNK (p-JNK) is also activated in
the spinal DRG after nerve injury, and this expression of p-JNK can
maintain mechanical allodynia.6
Curcumin is a polyphenol found in the dietary spice turmeric
(Curcuma longa Linn.). It is extracted from dried rhizomes of the
perennial herb, which is a member of the ginger family.7 Curcu-
min has been demonstrated to have a variety of biologic activities,
including anti-inﬂammatory activities and anticancer proper-
ities.8,9 Curcumin is known to exert its action through inhibitionnse.
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gated if curcumin would prevent the development of neuropathic
pain though its inhibitory action on p-ERK and p- JNK in spinal
DRG and reduce phosphorylation of NR1 (p-NR1) subunits of
N-methyl-D-aspartate in rats with CCI.Materials and Methods
Experiment animals
Thirty adult male Sprague Dawley rats (weighing 280 to 320 g)
were used in the experiments. Rats were randomly divided into
3 groups: the sham group (n ¼ 10), CCI group (n ¼ 10), and
curcumin group (n ¼ 10). The animals were housed under
optimal laboratory conditions, maintained on a natural light and
dark cycle (light cycle: 7:00 AM to 7:00 PM), and had a free access
to food and water ad libitum. All of the animal experiments were
performed in accordance with the National Institutes of Health
guidelines on animal care.
CCI procedure
Rats were anesthetized with enﬂurane in 60% nitric oxide/40%
oxygen during surgical procedures. Rats in the CCI and curcumin
groups underwent CCI surgery. CCI surgery was carried out as
described previously.11 The left sciatic nerve was exposed and,
proximal to the trifurcation, approximately 7 mm of the common
sciatic nerve was freed of adhering tissue. Four ligatures (chromic
gut [4-0]) were loosely tied around the nerve at intervals of
approximately 1 mm. The wounds were cleaned with saline,
closed with wound clips, and rats were returned to their cage
after recovering from anesthesia. Sham-operation control rats
underwent an identical surgical procedure as the CCI rats except
that the left sciatic nerve was without ligation.
Drug treatment schedule
Curcumin was purchased from Sigma (St. Louis, Missouri).
Curcumin suspension was prepared in a 0.5% carboxymethylcel-
lulose solution. Drug suspension was freshly prepared and admi-
nistered in a constant volume of 1 mL/100 g body weight. Due to
poor absorption, increasing the dose of curcumin did not neces-
sarily result in higher absorption. Sixty percent of the given dose
of curcumin was absorbed. It was detected in blood from
15 minutes to 24 hours after administration of curcumin.12
Treatment with curcumin at varying dose (15 to 60 mg/kg/d
PO) attenuated thermal hyperalgesia in a diabetic mouse model of
neuropathic pain.13 In the curcumin treatment group, therefore,
curcumin (50 mg/kg/d PO) was administered from 1 day before
CCI surgery to 7 days after CCI surgery. The rats in the control
group and CCI group received a control vehicle.
Behavior test
The experimenter who conducted the behavior test was
blinded to the nature of the experimental manipulation to avoid
bias. The behavior test for mechanical allodynia was performed
between 8:00 PM and 12:00 PM. Tactile allodynia was determined
by measuring the paw withdrawal thresholdwithdrawal thresh-
old (PWT) in response to probing with a series of von Frey
ﬁlaments. To quantify mechanical allodynia, a rat was placed
under a transparent plastic box on a metal mesh ﬂoor. PWT to a
series of calibrated von Frey ﬁlaments (Somedic, Ho¨rby, Sweden)
were measured according to the up-and-down protocol. The
examiner touched the plantar surface of the hindpaw with aselected ﬁlament. A positive response was deﬁned as a brisk
withdrawal or paw ﬂinching. Five stimuli using the selected
ﬁlament were applied at 5-second intervals. If there was no
withdrawal response to the initially selected ﬁlament with these
5 stimuli, a ﬁlament with a stronger stimulus was applied. If
the animal withdrew its hindpaw in response to any of the
5 stimuli, a ﬁlament of the next weaker stimulus was chosen.
The mechanical threshold was deﬁned as the minimal force
(in grams) initiating a withdrawal response. The measurements of
PWT were performed 1 day before CCI and 1, 3, 5, and 7 days
following CCI.
Western blot
After mechanical allodynia were measured on the seventh day
following CCI, rats were sacriﬁced for Western immunoblotting.
The L4/5 spinal DRG (ipsilateral side only) were quickly removed,
frozen immediately on dry ice, and stored at 701C until use. At
the time of assay, each spinal DRG sample was thawed and
homogenized in a lysis buffer (20 mM tris[hydroxymethyl]ami-
nomethane pH 8.0; 150 mM sodium chloride; 1 mM EDTA; 2 mM
sodium orthovanadate; 0.5 mM dithiothreitol; 10% glycerol; and
1% octylphenoxypolyethoxyethanol, a nonionic, nondenaturing
detergent) containing protease inhibitor cocktail (Roche,
Mannheim, Germany). After centrifuging at 12,000 rpm for
20 minutes at 41C, the supernatant was decanted from the pellet
and used for Western blot analyses. The concentration of protein
in the homogenate was measured using the Bio-Rad Protein Assay
Kit I (Bio-Rad, Hercules, California). The homogenate of equal
amounts of protein (50 mg of each protein sample) was boiled for
5 minutes at 1001C in gel loading buffer (0.5 M tris[hydroxy-
methyl]aminomethane, glycerol, 10% sodium dodecyl sulfate, and
0.5% bromophenol blue), run on 10% sodium dodecyl sulfate-
polyacrylamide gels, and then transferred to nitrocellulose mem-
brane at 60 V for 3 hours. The membranes were blocked in 3% to
5% nonfat dried milk in tris buffered saline (50 mM tris pH 7.4 and
10 mM sodium chloride) for 1 hour at room temperature and then
incubated overnight at 41C with the primary antibody against
p-ERK 1/2 at a dilution of 1:1000 and p-JNK (Santa Cruz Biotech-
nology, Santa Cruz, California) and p-NR-1 at a dilution of 1:500
(Upstate Biotechnology, Temecula, California). After washing with
tris buffered saline (50 mM tris pH 7.4 and 10 mM sodium
chloride), the membranes were incubated for 1 hour at room
temperature with peroxidase conjugated secondary antibody
(1:2000) and washed again. Proteins were detected using ECL
system (Amersham Biosciences, Buckinghamshire, England) and
band density was semiquantitatively analyzed with the National
Institutes of Health Image program. The blots were exposed to
autoradiographic ﬁlm (Eastman Kodak Co, Rochester, New York),
the ﬁlms were scanned into a computer, and the intensity of
immunoreactive bands of interest was quantiﬁed using Meta
Image series software.
Statistical analysis
Behavior-related data are presented as mean (SEM) and
analyzed using the SAS 8.0 statistical program (SAS Institute Inc,
Cary, North Carolina).
The behavior data were analyzed by using repeated measured
ANOVA, followed by Tukeys test to investigate differences at
different times in each group. The Kruskal–Wallis test was used to
determine differences in p-ERK, p-JNK, and p-NR1 among the
3 groups, and post hoc comparisons between groups were made
using Dunn’s test. A P value o 0.05 was considered statistically
signiﬁcant.
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Behavior test
There were no differences in the mechanical thresholds in the
sham group. However, a signiﬁcant reduction in the mechanical
thresholds was observed 1 day after nerve injury (vs pre-CCI; P o
0.05), thus indicating development of mechanical allodynia
(see Figure 1). In the CCI group, this mechanical allodynia was
observed during the 7 days following nerve injury. However,
curcumin treatment reversed the mechanical allodynia 7 days
after nerve ligation.
Western blot analysis
Quantiﬁcation of Western blots showed that a procedure of
nerve ligation resulted in increased levels of p-ERK, p-JNK, and
p-NR1 compared with those of the sham group (P o 0.05).40
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Figure 1. Effects of curcumin (50 mg/kg/d, PO) on mechanical threshold values to
von Frey in rats with chronic constriction injury (CCI) of the sciatic nerve. The data
are presented as mean (SEM) (n ¼ 10 each group). *P o 0.05 versus pre-CCI.
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Figure 2. Effects of curcumin (50 mg/kg/d, PO) on phosphorylated extracellular sign
phosphorylation of NR1 (p-NR1) in spinal dorsal root ganglion of rats with chronic const
10 each group). *P o 0.05 versus CCI group.However, there were no differences in the level of p-ERK, p-JNK,
and p-NR1 in the spinal DRG between the sham and curcumin
group (P 4 0.05) (Figure 2).Discussion
In our study curcumin reversed the development of mechan-
ical allodynia induced by CCI of the sciatic nerve. It suppresses
activation of ERK and JNK in the spinal DRG.
Recently, several studies have reported that ERK may have a
role in persistent hyperalgesia (ie, hypersensitivity to thermal and
mechanical stimuli).14,15 Phosphorylation of ERK may be required
for the modulation of nociceptive information produced by
intense noxious stimuli and/or peripheral tissue inﬂamma-
tion.14,15 Preventing ERK activation with mitogen extracellular
kinase inhibitors reduces chronic pain induced by nerve injury.16
ERK phosphorylation in the spinal DRG is correlated with neuro-
pathic pain behaviors.5 JNK is also rapidly activated in response to
environmentally stressful stimuli.17 After nerve injury, JNK acti-
vation primarily occurs in small diameter C-ﬁber neurons.6
Intrathecal infusion of the peptide JNK inhibitor D-JNKI-1 pre-
vented the development of mechanical allodynia.6 In our study,
curcumin suppressed phosphorylation of ERK and JNK. In addi-
tion, curcumin treatment reversed mechanical allodynia. Recent
studies have shown that curcumin is both a nitric oxide scavenger
and an inhibitor of inducible nitric oxide synthase expression.13,18
Curcumin is also known to reduce the amount of peroxynitrite
formed by the reaction between oxygen and nitric oxide and
generated from sodium nitroprusside.19 Earlier studies have
shown that oxidative stress and free radical species are involved
in neuropathic pain.20,21 Nitric oxide modulates spinal and
sensory neuron excitability that contributes to different pain
states.21 Inducible nitric oxide synthase is involved in the devel-
opment of hypersensitivity to pain in inﬂammatory and neuro-
pathic pain models.22 From our results, we determine that
curcumin has antinociceptive activity, possibly through its inhi-
bitory action on ERK and JNK in neuropathic pain models
associated with peripheral nerve injury. However, further studies
are warranted to explore the exact mechanism of curcumins
antinociceptive effect.* *Ra
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al-regulated kinase (p-ERK), phosphorylated Jun-N-terminal kinase (p-JNK), and
riction injury (CCI) of the sciatic nerve. The data are presented as mean (SEM) (n ¼
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been implicated in the activity-dependent plastic changes that
lead to the generation and maintenance of central sensitization,
which is believed to be an important mechanism underlying
chronic neuropathic pain. 23,24 In our study, 7 days after nerve
ligation there were no differences in the level of p-NR1 in the
spinal DRG between the sham and curcumin groups, whereas the
level of p-NR1 in the CCI group signiﬁcantly increased compared
with those of sham group. However, it was probably too early to
see the development of central sensitization. Therefore, another
study is needed to examine if long-term administration with
curcumin prevents central sensitization in rats with chronic
neuropathic pain.Conclusions
Treatment with curcumin during the early stages of perip-
heral neuropathy can prevent the development of chronic
neuropathic pain.Acknowledgments
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